Trading in Isofol’s shares commences today on Nasdaq Stockholm

GOTHENBURG, Sweden, October 21, 2021 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that the Company’s shares are admitted to trading on Nasdaq Stockholm.The shares of the Company will be traded with unchanged ticker ISOFOL and ISIN-code (SE0009581051). No new shares will be issued in connection with the shares being admitted to trading on Nasdaq Stockholm and the Company’s shareholders do not need to take any actions in connection with the listing. The prospectus prepared by the Company in connection with the listing was approved and